Profiling Mutant KRAS Protein Expression in Colorectal Cancer
Year: 2023
Type: dissertation
Abstract: KRAS acts as a molecular switch regulating activation of downstream pathways that result in cell survival, proliferation, migration, and differentiation. KRAS is the most frequently mutated oncoprotein in colorectal cancer (CRC). Mutant KRAS can be further subtyped based on mutational codon location and amino acid substitutions, termed point mutations. Currently, CRC patients are characterised by the presence or absence of a KRAS mutation. However, previous work in our group, indicate that not all KRAS mutants are the same. This, together with contrasting literature evidence drove us to focus on distinguishing differences between KRAS mutants at the proteomic level, by performing extensive high-throughput mass spectrometry analyses. Thus, the overall hypothesis for this thesis is that not all KRAS mutants are created equal and that different mutant isoforms have various effects within cells that lead to diverse biological influences within tumours which ultimately lead to variations in patient survival outcomes. The work carried out in this thesis identified differences between the different KRAS mutants. First, we show that certain KRAS mutants are prognostic of microsatellite stable (MSS) CRC patient outcomes, a group of patients that currently have very limited therapeutic options available to them. Next, investigation into protein expression between the different KRAS mutants revealed several proteins differentially expressed between specific KRAS mutant patient MSS CRC tumours. Additional protein interactomics investigations revealed KRAS interactomes are specific to the KRAS allele expressed and are influenced by therapeutic interventions. Ultimately, results from the research undertaken in this thesis demonstrate distinct variations between KRAS mutants at the proteomic level, which could be of relevance in the clinic for designing better treatments for MSS CRC patients.
Author: Nolan, Aoife
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7128661979
